Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation
- PMID: 15499549
- PMCID: PMC1182152
- DOI: 10.1086/426460
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation
Abstract
Recently, we showed that truncation of the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene caused mental retardation and severe neurological symptoms in two female patients. Here, we report that de novo missense mutations in CDKL5 are associated with a severe phenotype of early-onset infantile spasms and clinical features that overlap those of other neurodevelopmental disorders, such as Rett syndrome and Angelman syndrome. The mutations are located within the protein kinase domain and affect highly conserved amino acids; this strongly suggests that impaired CDKL5 catalytic activity plays an important role in the pathogenesis of this neurodevelopmental disorder. In view of the overlapping phenotypic spectrum of CDKL5 and MECP2 mutations, it is tempting to speculate that these two genes play a role in a common pathogenic process.
Figures
References
Electronic-Database Information
-
- BLAST, http://www.ncbi.nlm.nih.gov/BLAST/ (for searching short, nearly exact matches of FDFG sequence)
-
- ClustalW, http://www.ebi.ac.uk/clustalw/ (for alignment of human CDKL5, its orthologs, and closely related CDKL1, CDKL2, and CDKL3)
-
- GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for human genomic sequence containing CDKL5 [accession numbers AL109798 and Z92542], human CDKL5 cDNA [accession number NM_003159], human CDKL5 protein [accession number NP_003150], mouse Cdkl5 [accession number XP_356367], Fugu Cdkl5/Stk9 [accession number AAD28798], human CDKL1 [accession number NP_004187], human CDKL2 [accession number NP_003939], and human CDKL3 [accession number NP_057592])
-
- Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for RTT) - PubMed
References
-
- Bourdon V, Philippe C, Labrune O, Amsallem D, Arnould C, Jonveaux P (2001) A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients. Hum Genet 108:43–50 - PubMed
-
- Canagarajah BJ, Khokhlatchev A, Cobb MH, Goldsmith EJ (1997) Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90:859–869 - PubMed
-
- Carney RM, Wolpert CM, Ravan SA, Shahbazian M, Ashley-Koch A, Cuccaro ML, Vance JM, Pericak-Vance MA (2003) Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol 28:205–211 - PubMed
-
- Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch S, Thomas N, Hughes H, Hulten M, Ravine D, Sampson JR, Clarke A (2000) Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 9:1119–1129 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
